Core Viewpoint - The Hainan provincial government has introduced a series of policy measures to support the high-quality development of the biopharmaceutical industry, leveraging the unique advantages of the Hainan Free Trade Port to create a comprehensive policy support system for the entire industry chain [3]. Group 1: Support for R&D and Innovation - The policy continues to implement a research and development voucher program, providing financial rewards ranging from 400,000 to 10 million yuan based on the stage of product development [3]. - Enterprises participating in national bulk procurement will receive a reward of up to 3% of actual sales, with a maximum of 3 million yuan [3]. - A one-time reward of 2 million yuan will be given to enterprises that achieve international certification [3]. Group 2: Industry Expansion and Upgrading - A reward of 30 million yuan will be provided to municipalities for single projects that have a significant impact on the industry [3]. - The policy encourages mergers and acquisitions of local pharmaceutical companies, offering a 50% interest subsidy on loans for up to 2 years, with a maximum subsidy of 5 million yuan [3]. - New emerging industries such as biomanufacturing, medical beauty, special medical foods, and digital therapy will receive one-time rewards ranging from 200,000 to 1.5 million yuan based on specific criteria [4]. Group 3: Industry Ecosystem and Infrastructure - The policy aims to strengthen the industrial ecosystem by addressing shortcomings in the biopharmaceutical industry chain, including R&D innovation, pilot research, technology transfer, and clinical research [6]. - New or expanded investments of 5 million yuan or more will receive a reward of up to 500,000 yuan, based on 30% of the investment amount [6]. - Annual service amounts exceeding 3 million yuan will be rewarded at 5% of the service amount, with a maximum of 500,000 yuan [6]. Group 4: Internationalization and Talent Development - The policy supports existing enterprises in scaling up and enhancing quality, promoting international development [5]. - It emphasizes the importance of digital, intelligent, and green transformation for industry upgrading [6]. - Initiatives for talent introduction and educational collaboration are included to enhance the industry's influence and foster international cooperation [7].
我省出台政策措施 真金白银支持生物医药产业高质量发展
Hai Nan Ri Bao·2025-08-18 02:08